Abstract
A prime mechanism that contributes to the development and maintenance of alcoholism is the dysregulation of the hypothalamicāpituitaryāadrenal axis activity and the release of glucocorticoids (cortisol in humans and primates, corticosterone in rodents) from the adrenal glands. In the brain, sustained, local elevation of glucocorticoid concentration even long after cessation of chronic alcohol consumption compromises functional integrity of a circuit, including the prefrontal cortex (PFC), the hippocampus (HPC), and the amygdala (AMG). These structures are implicated in learning and memory processes as well as in orchestrating neuroadaptive responses to stress and anxiety responses. Thus, potentiation of anxiety-related neuroadaptation by alcohol is characterized by an abnormally AMG hyperactivity coupled with a hypofunction of the PFC and the HPC. This review describes research on molecular and epigenetic mechanisms by which alcohol causes distinct region-specific adaptive changes in gene expression patterns and ultimately leads to a variety of cognitive and behavioral impairments on prefrontal- and hippocampal-based tasks. Alcohol-induced neuroadaptations involve the dysregulation of numerous signaling cascades, leading to long-term changes in transcriptional profiles of genes, through the actions of transcription factors such as [cAMP response element-binding protein (CREB)] and chromatin remodeling due to posttranslational modifications of histone proteins. We describe the role of prefrontalāHPCāAMG circuit in mediating the effects of acute and chronic alcohol on learning and memory, and region-specific molecular and epigenetic mechanisms involved in this process. This review first discusses the importance of brain region-specific dysregulation of glucocorticoid concentration in the development of alcohol dependence and describes how persistently increased glucocorticoid levels in PFC may be involved in mediating working memory impairments and neuroadaptive changes during withdrawal from chronic alcohol intake. It then highlights the role of cAMPāPKAāCREB signaling cascade and histone acetylation within the PFC and limbic structures in alcohol-induced anxiety and behavioral impairments, and how an understanding of functional alterations of these pathways might lead to better treatments for neuropsychiatric disorders.
Introduction
Alcoholism is a chronic, often relapsing brain disorder characterized by periods of sustained, compulsive alcohol intake, relying in part on allostatic changes within the prefrontal cortex (PFC) and limbic structures [i.e., the hippocampus (HPC) and the amygdala (AMG)] [for review, see Ref. (1)]. This circuit plays key roles in behavior and cognitive function as well as in orchestrating neuroadaptive responses to stress and anxiety. The transition from recreational to alcohol dependence and compulsive alcohol drinking takes place via neuroadaptive changes in the stress-related neural circuits, caused partly by repeated cycles of alcohol intoxication and withdrawal (2, 3). A prime mechanism that contributes to the development and maintenance of alcoholism is the dysregulation of the hypothalamicāpituitaryāadrenal (HPA) axis activity (4) and the release of glucocorticoids (cortisol in humans and primates, corticosterone in rodents) from the adrenal glands. Clinical and preclinical evidence in both humans (5ā7) and rodents (4, 8, 9) have shown that acute and chronic alcohol consumption, as well as withdrawal, markedly affects plasma glucocorticoid levels. The release of glucocorticoids can influence brain function by readily crossing the bloodābrain barrier and exert effects through a dual glucocorticoid binding receptor system, i.e., the type I high affinity mineralocorticoid receptors (MRs) or the type II low affinity glucocorticoid receptors (GRs) (10), which act as ligand-dependent transcription factors to modulate target gene transcription. The MRs display a restricted expression in the brain, with highest densities in the HPC (11ā13). The GRs are widely distributed throughout the brain (10, 14, 15) with a predominant expression in the three areas involved in learning and memory and particularly sensitive to the effects of stress, namely, the PFC, the dorsal HPC, and the AMG (16ā18). Indeed, human studies of Cushingās syndrome have shown that sustained cortisol elevation over the years compromises the integrity of the HPCāPFC circuitry and thus influences the onset and/or the severity of cognitive decline in various tasks, including spatial, decision-making and working memory processes (19ā23). Further, sustained, high local concentration of glucocorticoids is responsible for long-lasting cognitive impairments occurring several weeks after the cessation of alcohol in rodents (24, 25) and abstinent patients (26, 27). As to how elevation of glucocorticoids might be implicated in the enduring cellular, molecular, and behavioral changes, it has been suggested that neuroadaptation induced by alcohol exposure involves the dysregulation of numerous signaling cascades, leading to long-term changes in transcriptional profiles of genes, through the actions of transcription factors such as [cAMP response element-binding protein (CREB)] and chromatin remodeling due to modifications of the posttranslational properties of histone proteins [for review, see Ref. (28)]. In the following, we provide an overview of how transcriptional and histone acetylation changes in the PFC, the HPC, and the AMG play a central role in the glucocorticoid-dependent neuroadaptation and behavioral deficits that occur during acute and chronic alcohol exposure. While this review focuses on aspects of how spatial and temporal changes in histone acetylation drive alcohol-induced alterations in neural plasticity and behavior, it should be emphasized that other histone modifications marks, such as histone phosphorylation and histone lysine methylation, occur in parallel and are also involved in the long-term adaptations in neural function and behavioral responses to alcohol exposure.
Brain Regional Glucocorticoid Response to Chronic Alcohol Exposure
Surprisingly, little is known about the long-lasting neuroadaptive changes of glucocorticoids caused by prolonged alcohol consumption and withdrawal within neural circuits involved in learning and memory and emotional events and about their behavioral consequences. Studies, including our own, have shown that the initial phase of alcohol withdrawal period produces elevation in both circulating and brain glucocorticoids levels (29ā31). Importantly, Little and colleagues (30) were first to show that during the initial phase of withdrawal from chronic (8āmonths in rats) alcohol consumption, rats and mice display an abnormal, exaggerated corticosterone level selectively in the medial PFC and the dorsal HPC. Strikingly, the authors found that withdrawal-associated excessive corticosterone response in the PFC persists for up to 2āmonths; therefore, long after, plasma corticosterone levels returned to baseline levels. In the PFC, the sustained elevation of corticosterone concentration was associated with enhanced GRs activation in mice undergoing a 2-week withdrawal period from chronic alcohol consumption (30). Further, administration of the GRs antagonist mifepristone or the dihydropyridine calcium channel nimodipine, given just prior to withdrawal from chronic alcohol exposure, not only reduced the rises in brain corticosterone but also prevented persistent memory deficits seen several weeks later in mice (24) or rats (32), suggesting that withdrawn-associated rise in glucocorticoid levels specifically within medial PFC may be an early index of maladaptive persistent behaviors in alcohol-dependent subjects. Indeed, chronic treatment with the GR antagonist mifepristone attenuated escalation of ethanol intake following intermittent ethanol vapor exposure (33) as well as the development of alcohol dependence and ultimately withdrawal-associated behavioral deficits (34). Endogenous glucocorticoids have been suggested to play an essential role in maintaining PFC-dependent cognitive functions, mainly via complex interaction with dopaminergic and glutamatergic receptors (35ā37). Both human and animal studies have demonstrated that alcohol withdrawal impairs a variety of the cognitive functions during tests that require cortical prefrontal processing (38ā40). As regards, pharmacological (hydrocortisone administration) or pathological (Cushingās disease) increase of cortisol was found to predict frontal cortex-based cognitive impairments including alterations in executive processes and working memory dysfunction (19, 23, 41ā43). Long-lasting deficits on tasks that rely on the PFC are also observed in rodent models in which chronic alcohol dependence is induced by chronic alcohol exposure or chronic intermittent ethanol that involves repeated cycles of exposure to alcohol vapors (44, 45). However, in addition to PFC dysfunction, there is evidence that a functional disconnection of brain network connectivity between the (dorsomedial) PFC and the central nucleus of the AMG may also contribute to the alcohol-induced working memory impairments in rats (46).
Recent work in our laboratory has employed in vivo microdialysis in freely moving mice to investigate effects of chronic alcohol treatment and withdrawal (early and prolonged) periods on brain corticosterone concentrations by simultaneously measuring time-course evolution of corticosterone concentration in the medial PFC and dorsal HPC seen before, during, and after completion of a working memory task in a T-maze (31, 47). This task is based on spontaneous alternation behavior, known to require intact connections between the two structures for successful performance (48, 49). Specifically, alternation behavior is the innate tendency of rodents to alternate at each successive trial the choice of the goal arm over a series of trials run in a T-maze (except for the first trial). From trial to trial, accurate performance at a given trial (N) requires for subjects to be able to discriminate the specific target trial Nāāā1 from the interfering trial Nāāā2. Thus, the target information required for successful performance varies from trial to trial, so that the subject is not only required to temporarily keep specific information in short-term storage but also reset it over successive runs. The resetting mechanisms and cognitive flexibility required to alternate over successive runs are major components of working memory processes. Working memory is a component of the sequential alternation task, since spontaneous alternation rates are dependent on the length of the inter-trial delay interval and/or the place of the trial in the series. Indeed, repetitive testing constitutes a potent source of proactive interference. Thus, the sequential alternation procedure is relevant to assess delay-dependent working memory in mice (50ā52). Using in vivo microdialysis in freely moving mice, we observed that early (1āweek) and protracted (6āweeks) withdrawal periods from prolonged (6āmonths) alcohol exposure causes an exaggerated corticosterone rise in the medial PFC. In addition, withdrawn mice having abnormal corticosterone concentration in the PFC displayed impaired working memory performance, effects that were not observed in animals still submitted to chronic alcohol consumption. Moreover, early and protracted withdrawal periods had no effect on the dynamic pattern of corticosterone response in the dorsal HPC, indicating that alcohol impacts glucocorticoid regulation in a brain region-specific fashion. During the 6-week withdrawal period, the degree of working memory impairment correlated with the magnitude of prefrontal corticosterone concentration, which is in accordance with the notion that there is a functional link between excessive corticosteroid signaling and PFC dysfunction (53ā55). Many neuroimaging studies have indicated consistently that structural and functional deficits in PFC regulatory regions are associated with chronic alcoholism [for review, see Ref. (56)]. Another study using SPECT imaging showed that detoxified alcoholic patients who relapsed 2āmonths later displayed working memory deficits associated with low blood flow in the medial frontal lobe (57). Given the importance of frontal cortical regions in the modulation of AMG reactivity and the mediation of effective emotion regulation, weakened PFC function associated with a specific functional disconnection between the PFC and the AMG has been proposed as an early index of neuroadaptation in alcohol dependence that predicts PFC-dependent cognitive impairments observed during abstinence (38, 39, 46).
Subsequently, we have studied whether local glucocorticoid blockade in the medial PFC would prevent the long-term deficits in working memory induced by protracted withdrawal from chronic alcohol consumption (31). Intraperitoneal administration of the corticosterone synthesis inhibitor metyrapone prior to testing prevented the withdrawal-associated working memory impairments, confirming the essential role of persistently increased glucocorticoid levels in behavioral impairments during withdrawal from chronic alcohol intake. Similarly, a single bilateral infusion of spironolactone into the medial PFC that diminished MR activation and to a lesser extent of mifepristone that diminished GRs activation fully restored working memory function in withdrawn mice. In contrast, neither spironolactone nor mifepristone had any effect when infused into the dorsal HPC, thus highlighting the importance of glucocorticoids specific to the PFC in neural substrates mediating the prolonged, detrimental effects of alcohol on behavioral performance. These findings are reminiscent of data showing that elevated glucocorticoid levels, via either systemic injection of corticosterone or local infusion of the GRs agonist RU 28362 into the medial PFC shortly before testing, similarly impair working memory (55), while the GRs antagonist RU 38486 infused into the PFC can restore stress-induced deficits in executive function (58). Collectively, these data support the view that long-term adaptive behavioral effects of chronic alcohol exposure are mediated in large part through long-lasting glucocorticoid dysregulation within the PFC circuitry.
Molecular Mechanisms Underlying Anxiety-Like and Alcohol-Drinking Behaviors: The Role of cAMPāPKAāCREB Cascade
The transcription factor CREB is a key downstream target of a variety of kinases, including cAMPāprotein kinase A (PKA), Ca2+/calmodulin-dependent kinase, and extracellular-regulated kinase/mitogen-associated protein kinase (ERK/MAPK) (59, 60). The resulting activation/phosphorylation of CREB and recruitment of CREB-binding protein (CBP) along with other transcriptional components enables transcription of specific CREB target genes, including those implicated in long-term memory and plasticity as well as in the development of anxiety-like and alcohol-drinking behaviors, such as the neuropeptide Y (NPY) and the brain-derived neurotrophic factor (BDNF) (61ā64). There is mounting evidence to support a role for phosphorylated CREB (pCREB) through a PKA-dependent mechanism and downstream CREB target genes, in the adaptive changes and behavioral effects associated with acute and chronic alcohol exposure [for review, see Ref. (65ā68)]. Acute and chronic ethanol exposures have long been known to modulate the various steps of the cAMP-dependent pathways in the rodent brain and in other cell systems (69ā71). Exposure to ethanol affects a cascade of events allowing for sustained translocation of PKA catalytic subunit into the nucleus (72), ultimately resulting in long-lasting increased CREB activation/phosphorylation (73) and downstream expression of many target genes (74). In this context, abnormal PKA-dependent CREB functioning has been implicated in the molecular mechanisms of neuroplasticity that underlie alcoholism and alcohol drinking. There is evidence for a biphasic temporal effect of ethanol on cAMPāPKA-dependent signaling cascade with acute and prolonged exposure to ethanol potentiating (75) and decreasing (76, 77), respectively, adenylyl cyclaseācAMPāPKA activity in the cortex and HPC (78) in mice. Using a combination of genetic or pharmacological approaches, Drosophila and rodents studies have shown that maintaining integrity of the cAMPāPKA activity is central to establishing sensitivity to the sedative effect of ethanol as well as in modulating ethanol consumption (79ā81). Acute withdrawal (24āh) from chronic ethanol treatment produced a decrease in Ser133āpCREB within specific neurocircuitry of the frontal, parietal, and piriform cortex in rats (82), suggesting the possibility that CREB-dependent events in these cortical structures may be involved in the development of alcohol dependence. Among the mechanisms responsible for reduced pCREB and downregulation of cAMP-dependent genes, chronic intermittent alcohol exposure has been shown to increase expression of the protein kinase inhibitor-Ī± (PKI-Ī±) in the PFC, nucleus accumbens, and AMG in Wistar rats (83). Given the wealth of data for the recruitment of the cAMPāPKA signaling pathways upon acute ethanol exposure, it has been proposed that the increased PKI-Ī± expression may be part of the adaptation of the cAMPāPKA pathway induced by intermittent alcohol exposure.
Investigations into the role of CREB in amygdaloid brain structures with regard to anxiety-like and alcohol-drinking behaviors have shown that CREB activity fluctuates depending on brain structures and alcohol āconditionā (acute, chronic, or withdrawal). For instance, a series of studies by Pandeyās group conducted in the rat AMG clearly indicate a strong relationship between decreased CREB phosphorylation and high anxiety-like responses associated with acute withdrawal from 2-week ethanol treatment (62, 82). Decreases in CREB phosphorylation and downstream cAMP-inducible genes, including NPY in the central and medial, but not the basolateral, nuclei of the AMG, have been associated with a predisposition to both anxiety-like and excessive alcohol-drinking behaviors in alcohol-preferring rats (60, 84ā86). Restoring CREB function to optimal level or enhancing NPY signaling in the central AMG prevented the onset of anxiety-like behaviors (84, 87, 88), while alcohol-associated anxiety disorders can be mimicked by pharmacological blockade of PKA in ethanol-naĆÆve-preferring rats or non-preferring rats (60, 84). Thus, anxiety-induced downregulation of CREB function in the AMG may constitute a critical neuroadaptation central to the development and maintenance of alcohol dependence. As regards, dysregulation of the PFC associated with a functional disconnection between the PFC and AMG central nucleus during abstinence and renewed access to alcohol has been implicated in long-lasting cognitive impairment and excessive alcohol drinking in rats (46).
Clinical evidence from alcohol-dependent patients also indicates that acute and protracted withdrawal/abstinence is strongly associated with depressive-like behaviors, such as anhedonia.
The catecholamines dopamine and noradrenaline via the cAMPāPKAāCREB signaling cascade provide an essential modulatory influence on PFC-dependent behaviors producing an inverted āU-shapedā doseāresponse influence, whereby moderate levels improve PFC function while either too little or too much catecholamines lead to cognitive impairments [for review, see Ref. (89)]. A number of studies including work in our laboratory (51) have shown that blocking the cAMPāPKAāCREB signaling cascade via local infusion of Rp-cAMPS (a compound known to inhibit CREB phosphorylation) into the PFC prevents the impairing effect of stress or aging on working memory performance, while drugs that increase cAMPāPKA signaling either by direct intra-PFC infusion of the cAMP analog Sp-cAMPS or dopamine D1 receptor agonist or i.p. administration of the phosphodiesterase (PDE) inhibitor Rolipram impair cognitive functions [for reviews, see Ref. (89ā91)]. As mentioned above, we recently reported that consumption of an alcohol-containing liquid diet for 6āmonths followed by a 1-week withdrawal period produces working memory impairment in a T-maze spontaneous alternation task in mice, which persists for at least 6āweeks after the cessation of alcohol intake (31, 47). Moreover, withdrawn mice displaying impaired working memory performance were those that had the lowest pCREB level in the PFC along with a persistent rise of prefrontal corticosterone concentration. Because glucocorticoids in the PFC interact with Ī²-adrenoceptorācAMP/PKA activity to influence working memory function (92), one route by which elevated glucocorticoid levels may impair PFC-mediated cognitive function long after the cessation of alcohol exposure is by inhibiting the cAMPāPKA cascade. In this context, growing evidence supports a central role for PDE, which is responsible for the breakdown of cAMP, in the regulation of alcohol drinking in rodents [for review, see Ref. (93)]. For example, treatment with various PDE4 inhibitors, including rolipram, produces long-lasting reduction of alcohol intake and preference in C57BL/6J mice (94). Chronic rolipram treatment also results in sustained reduction of alcohol seeking and consumption in alcohol-preferring rats (95, 96). As mentioned earlier, mice subjected to 1- or 6-week alcohol withdrawal from chronic alcohol consumption exhibited working memory impairments accompanied by enhanced anxiety level (at 1āweek only) as well as persistently elevated corticosterone and sustained decreased pCREB levels in the PFC. Intraperitoneal administration of the PDE4 inhibitor, rolipram, before working memory testing abolished these withdrawal-associated behavioral, endocrine, and neuronal alterations (31) ā a finding consistent with other observation, which demonstrated that in rats, heightened anxiety during acute alcohol withdrawal was accompanied by elevated expression of Pde10a isoform mRNA levels in interconnected medial PFCāAMG circuit, which persisted in the AMG after protracted (6āweeks) alcohol withdrawal (97). Together, these observations strongly support further research with regard to isoform-specific PDE-selective inhibitors that are promising pharmacotherapy targets for alcohol use disorders.
As discussed above, long-term adaptive behavioral effects of chronic alcohol exposure are mediated in large part through long-lasting glucocorticoid dysregulation within the PFC but not the dorsal HPC. Confirming differential sensitivity of the PFC and dorsal HPC to chronic alcohol-induced damage, recent work in our laboratory has shown that, unlike the PFC in which withdrawal from prolonged alcohol intake caused persistent working memory impairments along with sustained inhibition of the cAMPāPKAāCREB signaling cascade, both alcohol (unimpaired) and alcohol withdrawal (impaired) mice display reduced levels of pCREB in the dorsal HPC (namely, the CA1 region), compared with water-drinking mice (31, 47). Furthermore, intraperitoneal administration of rolipram was able to correct the deficit in pCREB in the dorsal HPC but did not reverse working memory impairments in withdrawn animals (47). Together, these observations support the notion that disruption of the cAMPāPKAāCREB signaling cascade specifically in the PFC (but not in the dorsal HPC) has an essential role in promoting long-term neuroadaptive changes accompanying persistent behavioral changes during withdrawal from chronic alcohol intake. Interestingly, early pioneering work in our laboratory emphasized a key role for PKAāCREB signaling as a sustained āmolecular switchā that gradually converts acute ādrugā responses into relatively stable adaptations that contribute to drug and alcohol addiction-mediated long-lasting neural and behavioral plasticity. Under conditions of drug- and food-reinforced behavior, drug-induced reward impaired spatial discrimination learning in a Y-maze task and caused drastic decreases in pCREB and downstream target c-Fos expression in the dorsal HPC and the PFC while sparing the cued version of the task and pCREB in the dorsal striatum in mice (98). Further, pharmacological blockade of cAMPāPKA cascade into the striatum before training normalized CREB activity within the HPCāPFC circuit and, as subsequently, prevented the drug-induced modulation of multiple memory systems.
Emerging evidence indicates that brain region-specific alteration of CREB signaling is also an important regulator involved in depression-like behavior that emerges during abstinence following alcohol drinking. As a key symptom of clinical depression, anhedonia reflects reduced interest in enjoying pleasure-seeking behavior and plays a key role in relapse (99, 100) and in the perpetuation of excessive alcohol consumption in dependent individuals (101). Important clinical evidence clearly demonstrated that the persistence and intensity of some behavioral withdrawal symptoms positively correlated with anhedonia scales in detoxified alcohol-dependent subjects (102), extending previous findings of strong correlation between anhedonia and substance-related symptoms particularly in detoxified opiate-dependent subjects (103). The presence of depression-related behavioral phenotypes during protracted abstinence was also reported in rodent models (104ā106). In mice undergoing 2āweeks of abstinence from chronic alcohol consumption, the persistent increase in plasma corticosterone response and upregulation of GR expression correlated with the development of depressive-like phenotypes, including anhedonia and helplessness (105), and reduced hippocampal neurogenesis (104). Further, there are several lines of evidence that suggest that downregulation of BDNFāTrKBāCREB signaling pathway may serve as a common link between the development of alcohol-induced depression-like symptoms and reduced hippocampal neurogenesis (104, 105, 107, 108). Finally, since enhancing the BDNFāCREB activity through pharmacological treatments with various classes of antidepressant drugs or environmental enrichment abolished the alcohol-induced anhedonia and depressive behaviors seen during protracted abstinence (104, 107, 108), supporting the hypothesis that BDNFāCREB signaling pathway may be a potential therapeutic target for interventions in alcoholismādepression coincidence.
Alcohol Alters the Balance Between Histone Acetylation: Deacetylation
Equally important for providing precise, long-lasting changes in brain function associated with alcohol intake are histone modifications, which exert lasting control over transcriptional activity of target genes through modifications of the chromatin structure and function that make the DNA less or more accessible to transcription factors and enzymes. The basic unit of chromatin, the nucleosome, is a histone octamer wrapped by approximately 147 base pairs of DNA. Each core histone (H2A, H2B, H3, and H4) has a highly conserved amino (N)-terminal tail, which is subject through a range of posttranslational modification (PTM) marks at distinct residues/sites including acetylation and methylation of lysine residues and phosphorylation of serine residues (109). Histones acetylation and phosphorylation are associated with transcriptional activation, whereas histone methylation reflects both transcriptional activation and repression depending on the specific site and context of the modification. An important feature of histone PTMs is that they can influence each other in a synergistic or antagonistic manner, leading to a complex āhistone codeā (110). Of these histone PTMs, histone acetylation is the most widely investigated in terms of epigenetic mechanisms underlying region-specific changes in brain gene networks required for long-term memory processes. Many rodent studies have detailed how different learning paradigms trigger distinct histone acetylation patterns in the brain, which are accompanied by region-, task-, and age-specific changes in memory-associated genes [for reviews, see Ref. (111ā115)]. For instance, increased acetylation of histones, H3 and H4, occurred in the dorsal HPC or the dorsal striatum, depending on whether mice were subjected to a spatial or cued training in the water maze task, respectively (116, 117).
The degree of histone acetylation/deacetylation is finely orchestrated by dynamic balance of antagonistic enzymes that āwriteā (HATs) and āeraseā [histone deacetylases (HDACs)] acetylation sites (113, 118ā121). Systemic administration of HDAC inhibitors (HDACi), such as sodium butyrate (NaB) or trichostatin A (TSA), can improve memory formation and also prevent or reverse cognitive impairments associated with normal and pathological aging. However, this enhancing effect of HDACi on HPC-dependent memory required accurate CREB activity (116, 117, 122). Furthermore, infusing HDACi directly to the HPC was not only effective in promoting HPC-dependent learning and memory processes but can also influence relative use of multiple memory processes by affecting transcriptional events within subcortical and PFC cortical structures (116, 123).
A growing set of studies in both humans and animals have indicated that alcohol exposure causes widespread, dynamic changes of histone acetylation patterns, and thereby dysregulation in gene expression profiles across multiple brain regions (28, 124ā126). Most of the studies have focused on the two histones H3 and H4 acetylation and chromatin-related events within the PFC, the HPC, and the AMG. In mouse and rat brain, studies reported that alcoholās effects on histone acetylation patterns depend on the alcohol treatment paradigm, the timing of alcohol exposure or withdrawal, and brain structures examined, and even within a structure, alcohol can affect differently subregions. For example, work from Pandeyās lab has shown that anxiolytic-like responses caused by acute ethanol i.p. injection were accompanied by increased HAT CBP activity and associated increased acetylation of histone H3 at lysine 9 and histone H4 at lysine 8 (H3K9 and H4K8, respectively) leading to rapid elevation of NPY (mRNA and protein level) specifically in the central and medial, but not the basolateral amygdaloid, nuclei (125). The same group observed that a 2-week ethanol exposure followed by acute ethanol withdrawal (24āh) switches alcoholās effect to anxiogenic-like responses, effects that involve a shift from HDAC hypoactivity to HDAC hyperactivity and subsequently decreased histone acetylation and transcriptional repression of NPY function in the two AMG nuclei (125, 127, 128). Correcting histone acetylation deficits in the AMG via administration of the pan HDACi TSA can reverse the rapid tolerance to the anxiolytic effects of ethanol (128) and prevent the development of alcohol withdrawal-related anxiety in rat (125). Alcohol-induced neuroadaptation in the AMG also implicated deficits of BDNF activity and its target [activity-regulated cytoskeleton-associated protein (Arc)], two key signaling factors involved in synaptic transmission and plasticity. While acute ethanol exposure caused an upregulation of BDNFāArc signaling pathway and subsequently increased dendritic spine densities in the central and medial AMG nuclei, withdrawal from prolonged ethanol exposure or binge ethanol consumption potently inhibited BDNF and Arc expression and reduced dendritic arborization in these nuclei and other regions, leading to increased anxiety-like and drinking behaviors (66, 129, 130). Importantly, these long-lasting adaptive changes associated with alcohol dependence were reversed upon treatment with the HDACi TSA (61, 128ā130). In another study by Moonat and colleagues (61) examining the role of HDAC2 in the development of alcohol dependence, investigators found lower baseline BDNF protein levels in the AMG (and also the bed nucleus of stria terminalis) of alcohol-preferring rats, a well-established model used to study the genetic predisposition to alcoholism (131), relative to the low-drinking NP rats. In addition, innate HDAC2 overexpression and decreased H3K9 acetylation in the central nucleus of alcohol-preferring rats correlated with low levels of BDNF, Arc, and NPY and was accompanied with high levels of anxiety-like and alcohol-drinking behaviors. These HDAC2-associated molecular and behavioral deficits were rescued via specific knockdown of HDAC2 expression either by direct infusion of small interfering RNA (siRNA) against HDAC2 into the central AMG nucleus (61, 66) or by TSA treatment (127, 130, 132). Collectively, these observations raised the possibility that adaptive epigenetic changes involving HDACs, and in particular HDAC2, in the AMG may be important regulatory mechanisms that underlie expression of genes implicated in the development and pathogenesis of alcohol dependence.
Using a chronic intermittent ethanol exposure model, a robust H3K9 hyperacetylation was seen in the AMG and cortical areas of rats, which displayed motivation to self-administer ethanol after a 6-h withdrawal period, compared with non-dependent rats (133). Treatment with the HDACi NaB or MS-275 (i.p. or i.c.v.) was able to counteract the effects of alcohol in dependent rats but not in non-dependent rats. Treatment with NaB, when administrated prior to ethanol self-administration, was also able to reverse H3K9 hyperacetylation and counteract excessive alcohol intake and relapse in alcohol-dependent rats. In order to identify brain region-specific regulatory molecular (epigenetic) signatures potentially involved in adaptive processes that lead to alcohol tolerance and dependence, Smith and colleagues (134) recently examined brain regional expression network responses to acute (0ā8āh) and late (72āh to 7ādays) withdrawal from chronic intermittent ethanol exposure in mice. Remarkably, the authors showed that neuroinflammatory responsive genes can be seen across all brain regions at 0ā8āh after the beginning of alcohol withdrawal, while sustained over-representation for subset groups of genes related to neurodevelopment and synaptic plasticity (such as Bdnf) and to histone acetylation (such as HDAC4 and HDAC6) and histone/DNA methylation are found at 3- to 7-day-withdrawal periods specifically in the PFC and the HPC. These results illustrate how transient and persistent histone acetylation changes could serve as a key mechanism for tight regulation of the expression of large sets of genes within specific brain regions of animals predisposed to excessive ethanol drinking or exposed to protracted abstinence. A functional disconnection of the CeAāPFC circuit during abstinence (72āh) and renewed access to alcohol has been recently implicated in long-lasting PFC-dependent cognitive dysfunction and the development of anxiety-like behavior, and more specifically, the resulting PFC hypofunction was shown to facilitate the transition from moderate to excessive and uncontrolled alcohol intake in rats (46).
Persistent changes of the HAT CBP activity and H4 acetylation were observed in the frontal cortex of C57BL/6 mice given 5-month chronic alcohol consumption followed by a 15-day withdrawal period (135). In that study, withdrawal-associated H4 hypoacetylation correlated with neuroinflammatory damage and the persistently altered memory and anxiety-related behaviors. Nonetheless, these changes were absent in mice lacking the Toll-like receptor 4 (TLR4) that have undergone the same treatment, suggesting a critical role for TLR4-mediated epigenetic modifications in mediating long-lasting deleterious effects of chronic alcohol on PFC-dependent behaviors (135). This is in line with findings in our laboratory showing a robust decrease in histone H4 acetylation in the medial PFC of C57/BL mice at 1āweek after withdrawal from chronic alcohol consumption; this decrease was maintained for at least 6āweeks after alcohol withdrawal and correlated with the persistently impairment of working memory noted during abstinence (31, 47). Alcoholās effects on H4 acetylation closely paralleled effects on CREB activation in the PFC. Further, systemic delivery of corticosterone inhibitor metyrapone or local intra-PFC blockade of MRs (via spironolactone) or GRs (via mifepristone) similarly reversed long-lasting deficits in pCREB and H4 acetylation levels in the PFC and alleviated working memory deficits associated with alcohol withdrawal (31). Thus, these findings suggest that long-lasting glucocorticoid-induced neuroadaptive changes in CREB and H4 acetylation in the PFC may be involved in the enduring working memory impairments caused by prolonged alcohol consumption and withdrawal. Cumulative evidence indicates that structural and functional integrity of the HPC was also compromised in rats after prolonged alcohol exposure and even greatest alterations were found after cessation of alcohol exposure (136ā138). Prolonged ethanol intake caused enduring deficits in HPC-dependent spatial reference memory in the water maze (138ā140). Chronic ethanol treatment also caused long-lasting decrease of histone acetylation in the dorsal HPC. However, contrary to the PFC where there was strong relationship between alcohol-induced decrease of H4 acetylation and long-lasting working memory impairments, H4 acetylation in the HPC (the CA1 region) was decreased in behaviorally āunimpairedā alcohol-treated mice and even continued to decrease in āimpairedā withdrawal-treated mice, compared with water-treated mice (31, 47). However, the drugs that prevented alcoholās effects in the PFC did not rescue alcoholās effects on HPC function, underscoring a region-specific influence of regulatory epigenetic signature on adaptive processes that lead to alcohol tolerance and dependence.
Alcohol and Histone H3 Modification Cross Talks
Ethanolās effects on histone H3 phosphorylation at serine 10 (H3ser10phos) and concurrent H3 phosphoacetylation are of particular interest as their rapid elevation is critical for leaning/memory-associated induction of immediate-early genes (e.g., c-fos and egr-1) (141ā143), an effect shown to mediate adaptive responses to psychology stressful events such as forced swimming or novelty stress paradigm exposure (142ā145). In rats, acute ethanol dose dependently alters the number of H3ser10phos in the dentate granular cells of the HPC, and these changes are paralleled by changes in c-fos protein expression (146). The same group has shown that, in ethanol-dependent rats, both H3ser10phos and c-fos levels are reduced in dentate granule cells during excessive alcohol intake, while opposite effects are evident at withdrawal peak in the HPC. Elevation of H3ser10phos and histone H3 phosphoacetylation is achieved through a direct interaction of the GR with [mitogen- and stress-activated protein kinase 1 (MSK1)] and ETS-domain protein Elk-1 that are downstream of the ERK/MAPK signaling cascade (143, 145, 147, 148). Conversely, nuclear type 1 protein phosphatase (PP1), a nuclear protein Ser/Thr phosphatase that acts as a universal negative regulator of memory and synaptic plasticity, interfered with H3Ser10phos in several brain areas such as the HPC and the AMG (149ā152).
Combinatorial modifications of acetylated H3 and histone H3 lysine 4 trimethylation (H3K4me3) have been implicated in long-term adaptive changes in the HPC resulting from prolonged alcohol intake (126, 153). Using a 3-week mouse model of chronic ethanol consumption, Stragier and colleagues (154) recently reported that ethanol-induced BDNF-mediated neuroplastic changes in the HPC are controlled by combinatorial modifications of acetylated H3 and H3K4me3 around individual Bdnf gene promoters in dorsal CA3 region and the dentate gyrus and by decreased Bdnf DNA methylation in CA1āCA3 regions of the HPC. These ethanol-induced changes were associated with a deficit in HPC-dependent (contextual fear and novel recognition object) memory while sparing AMG-based cued fear memory. Chronic intermittent ethanol vapor exposure followed by 2ā5ādays of abstinence robustly and selectively increased histone H3K9 acetylation and DNA demethylation in PFC neurons with a parallel decrease of H3K9 methylation repressive mark as well as a downregulation of a set of histone methyltransferases (HMT) (155, 156). These changes mostly occurred after ethanol removal and contributed to the development of physical dependence on alcohol through an adaptive long-lasting upregulation of the NMDA receptor 2B (NR2B) gene expression (155). Moreover, systemic treatment with TSA during ethanol exposure increased H3K9 acetylation at the NR2B promoter in PFC neurons and potentiated voluntary ethanol consumption (157). Together, these data suggest that persistent upregulation of the NR2B-containing NMDA receptors through deregulation of the balance between histone H3K9 acetylation and methylation states in the PFC may act as a potentially important contributor to the development of alcohol dependence.
Concluding Remarks
This review summarizes recent advances in our comprehension of endocrine, epigenetic, and transcriptional changes that serve as determining factors in controlling alcohol-associated changes in the expression of gene networks and behavior and play a central role in the regulation of alcohol dependence, withdrawal, and relapse (Figure 1). Most of the studies conducted thus far focused mainly on epigenetic and transcriptional regulation of adaptive responses to acute and chronic alcohol that occur within a single brain region (mostly the AMG). This review highlights new evidence from clinical and preclinical studies on how long-term adaptations arising from disruption of the fine coordination of highly interconnected brain structures within a circuit, including, but not limited to, the PFC, the HPC, and the AMG, may contribute to excessive alcohol consumption and alcohol dependence as well as behavior impairments. The findings reviewed in this article support the view that brain region- and cell type-specific histone acetylation modification (both in terms of global/genome-wide changes as well as promoter-specific changes) is a key mechanism underlying anxiety-like and alcohol-drinking behaviors. Thus, treatments designed to counteract alcohol-associated epigenetic changes may be promising targets for novel medications in the treatment of alcoholism.
Figure 1
Statements
Author contributions
NM and DB contributed to the writing of this review article.
Funding
This work was supported by a grant from FRA (Fondation pour la Recherche en Alcoologie, Paris, France).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
McEwenBS. The brain on stress: toward an integrative approach to brain, body, and behavior. Perspect Psychol Sci (2013) 8(6):673ā5.10.1177/1745691613506907
2
HeiligMKoobGF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 30(8):399ā406.10.1016/j.tins.2007.06.006
3
BreeseGRSinhaRHeiligM. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol Ther (2011) 129(2):149ā71.10.1016/j.pharmthera.2010.09.007
4
RichardsonHNLeeSYOāDellLEKoobGFRivierCL. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci (2008) 28(8):1641ā53.10.1111/j.1460-9568.2008.06455.x
5
LovalloWRDickensheetsSLMyersDAThomasTLNixonSJ. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin Exp Res (2000) 24(5):651ā8.10.1111/j.1530-0277.2000.tb02036.x
6
AdinoffBRuetherKKrebaumSIranmaneshAWilliamsMJ. Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin Exp Res (2003) 27(9):1420ā7.10.1097/01.ALC.0000087581.13912.64
7
SinhaRFoxHCHongKIHansenJTuitKKreekMJ. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry (2011) 68(9):942ā52.10.1001/archgenpsychiatry.2011.49
8
RasmussenDDBoldtBMBryantCAMittonDRLarsenSAWilkinsonCW. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin Exp Res (2000) 24(12):1836ā49.10.1111/j.1530-0277.2000.tb01988.x
9
ZorrillaEPValdezGRWeissF. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) (2001) 158(4):374ā81.10.1007/s002130100773
10
ReulJMde KloetER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology (1985) 117(6):2505ā11.10.1210/endo-117-6-2505
11
ArrizaJLWeinbergerCCerelliGGlaserTMHandelinBLHousmanDEet alCloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science (1987) 237(4812):268ā75.10.1126/science.3037703
12
ArrizaJLSimerlyRBSwansonLWEvansRM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron (1988) 1(9):887ā900.10.1016/0896-6273(88)90136-5
13
ReulJMvan den BoschFRde KloetER. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol (1987) 115(3):459ā67.10.1677/joe.0.1150459
14
SecklJRDicksonKLYatesCFinkG. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res (1991) 561(2):332ā7.10.1016/0006-8993(91)91612-5
15
JoelsMDe KloetER. Coordinative mineralocorticoid and glucocorticoid receptor-mediated control of responses to serotonin in rat hippocampus. Neuroendocrinology (1992) 55(3):344ā50.10.1159/000126135
16
FuxeKCintraAHarfstrandAAgnatiLFKaliaMZoliMet alCentral glucocorticoid receptor immunoreactive neurons: new insights into the endocrine regulation of the brain. Ann N Y Acad Sci (1987) 512:362ā93.10.1111/j.1749-6632.1987.tb24974.x
17
CintraABhatnagarMChadiGTinnerBLindbergJGustafssonJAet alGlial and neuronal glucocorticoid receptor immunoreactive cell populations in developing, adult, and aging brain. Ann N Y Acad Sci (1994) 746:42ā61; discussion 61ā3.10.1111/j.1749-6632.1994.tb39210.x
18
PatelPDLopezJFLyonsDMBurkeSWallaceMSchatzbergAF. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res (2000) 34(6):383ā92.10.1016/S0022-3956(00)00035-2
19
StarkmanMNGiordaniBBerentSSchorkMASchteingartDE. Elevated cortisol levels in Cushingās disease are associated with cognitive decrements. Psychosom Med (2001) 63(6):985ā93.10.1097/00006842-200111000-00018
20
StarkmanMN. Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinol Metab Clin North Am (2013) 42(3):477ā88.10.1016/j.ecl.2013.05.010
21
LupienSJde LeonMde SantiSConvitATarshishCNairNPet alCortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 1(1):69ā73.10.1038/1149
22
PatilCGPrevedelloDMLadSPVanceMLThornerMOKatznelsonLet alLate recurrences of Cushingās disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab (2008) 93(2):358ā62.10.1210/jc.2007-2013
23
TerfehrKWolfOTSchlosserNFernandoSCOtteCMuhtzCet alHydrocortisone impairs working memory in healthy humans, but not in patients with major depressive disorder. Psychopharmacology (Berl) (2011) 215(1):71ā9.10.1007/s00213-010-2117-z
24
JacquotCCroftAPPrendergastMAMulhollandPShawSGLittleHJ. Effects of the glucocorticoid antagonist, mifepristone, on the consequences of withdrawal from long term alcohol consumption. Alcohol Clin Exp Res (2008) 32(12):2107ā16.10.1111/j.1530-0277.2008.00799.x
25
KesnerRPChurchwellJC. An analysis of rat prefrontal cortex in mediating executive function. Neurobiol Learn Mem (2011) 96(3):417ā31.10.1016/j.nlm.2011.07.002
26
KeedwellPAKumariVPoonLMarshallEJCheckleySA. Information processing deficits in withdrawing alcoholics. Addict Biol (2001) 6(3):239ā45.10.1080/13556210120056571
27
ErricoALKingACLovalloWRParsonsOA. Cortisol dysregulation and cognitive impairment in abstinent male alcoholics. Alcohol Clin Exp Res (2002) 26(8):1198ā204.10.1111/j.1530-0277.2002.tb02656.x
28
MoonatSPandeySC. Stress, epigenetics, and alcoholism. Alcohol Res (2012) 34(4):495ā505.
29
RoseAKShawSGPrendergastMALittleHJ. The importance of glucocorticoids in alcohol dependence and neurotoxicity. Alcohol Clin Exp Res (2010) 34(12):2011ā8.10.1111/j.1530-0277.2010.01298.x
30
LittleHJCroftAPOāCallaghanMJBrooksSPWangGShawSG. Selective increases in regional brain glucocorticoid: a novel effect of chronic alcohol. Neuroscience (2008) 156(4):1017ā27.10.1016/j.neuroscience.2008.08.029
31
DominguezGBelzungCPierardCDavidVHenkousNDecorteLet alAlcohol withdrawal induces long-lasting spatial working memory impairments: relationship with changes in corticosterone response in the prefrontal cortex. Addict Biol (2016).10.1111/adb.12371
32
BrooksSPCroftAPNormanGShawSGLittleHJ. Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase.āNeuroscience (2008) 157(2):376ā84.10.1016/j.neuroscience.2008.09.010
33
VendruscoloLFBarbierESchlosburgJEMisraKKWhitfieldTWJrLogripMLet alCorticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci (2012) 32(22):7563ā71.10.1523/JNEUROSCI.0069-12.2012
34
Sharrett-FieldLButlerTRBerryJNReynoldsARPrendergastMA. Mifepristone pretreatment reduces ethanol withdrawal severity in vivo. Alcohol Clin Exp Res (2013) 37(8):1417ā23.10.1111/acer.12093
35
MizoguchiKIshigeAAburadaMTabiraT. Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience (2003) 119(3):887ā97.10.1016/S0306-4522(03)00105-2
36
MizoguchiKIshigeATakedaSAburadaMTabiraT. Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. J Neurosci (2004) 24(24):5492ā9.10.1523/JNEUROSCI.0086-04.2004
37
YuenEYLiuWKaratsoreosINFengJMcEwenBSYanZ. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc Natl Acad Sci U S A (2009) 106(33):14075ā9.10.1073/pnas.0906791106
38
OāDalyOGTrickLScaifeJMarshallJBallDPhillipsMLet alWithdrawal-associated increases and decreases in functional neural connectivity associated with altered emotional regulation in alcoholism. Neuropsychopharmacology (2012) 37(10):2267ā76.10.1038/npp.2012.77
39
PfefferbaumADesmondJEGallowayCMenonVGloverGHSullivanEV. Reorganization of frontal systems used by alcoholics for spatial working memory: an fMRI study. Neuroimage (2001) 14(1 Pt 1):7ā20.10.1006/nimg.2001.0785
40
MoselhyHFGeorgiouGKahnA. Frontal lobe changes in alcoholism: a review of the literature. Alcohol Alcohol (2001) 36(5):357ā68.10.1093/alcalc/36.5.357
41
CerqueiraJJPegoJMTaipaRBessaJMAlmeidaOFSousaN. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J Neurosci (2005) 25(34):7792ā800.10.1523/JNEUROSCI.1598-05.2005
42
Leon-CarrionJAtutxaAMMangasMASoto-MorenoAPumarALeon-JustelAet alA clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clin Endocrinol (Oxf) (2009) 70(2):192ā200.10.1111/j.1365-2265.2008.03355.x
43
VazLJPradella-HallinanMBuenoOFPompeiaS. Acute glucocorticoid effects on the multicomponent model of working memory. Hum Psychopharmacol (2011) 26(7):477ā87.10.1002/hup.1230
44
AbernathyKChandlerLJWoodwardJJ. Alcohol and the prefrontal cortex. Int Rev Neurobiol (2010) 91:289ā320.10.1016/S0074-7742(10)91009-X
45
VetrenoRPHallJMSavageLM. Alcohol-related amnesia and dementia: animal models have revealed the contributions of different etiological factors on neuropathology, neurochemical dysfunction and cognitive impairment. Neurobiol Learn Mem (2011) 96(4):596ā608.10.1016/j.nlm.2011.01.003
46
GeorgeOSandersCFreilingJGrigoryanEVuSAllenCDet alRecruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking. Proc Natl Acad Sci U S A (2012) 109(44):18156ā61.10.1073/pnas.1116523109
47
DominguezGDagnasMDecorteLVandesquilleMBelzungCBeracocheaDet alRescuing prefrontal cAMP-CREB pathway reverses working memory deficits during withdrawal from prolonged alcohol exposure.āBrain Struct Funct (2016) 221(2):865ā77.10.1007/s00429-014-0941-3
48
LeeIKesnerRP. Differential roles of dorsal hippocampal subregions in spatial working memory with short versus intermediate delay. Behav Neurosci (2003) 117(5):1044ā53.10.1037/0735-7044.117.5.1044
49
SpellmanTRigottiMAhmariSEFusiSGogosJAGordonJA. Hippocampal-prefrontal input supports spatial encoding in working memory. Nature (2015) 522(7556):309ā14.10.1038/nature14445
50
ChauveauFCelerierAOgnardRPierardCBeracocheaD. Effects of ibotenic acid lesions of the mediodorsal thalamus on memory: relationship with emotional processes in mice. Behav Brain Res (2005) 156(2):215ā23.10.1016/j.bbr.2004.05.026
51
VandesquilleMBaudonnatMDecorteLLouisCLestagePBeracocheaD. Working memory deficits and related disinhibition of the cAMP/PKA/CREB are alleviated by prefrontal alpha4beta2*-nAChRs stimulation in aged mice. Neurobiol Aging (2013) 34(6):1599ā609.10.1016/j.neurobiolaging.2012.10.006
52
BeracocheaDJaffardR. Memory deficits subsequent to chronic consumption of alcohol in mice: an analysis based on spontaneous alternation behavior. Behav Brain Res (1985) 15(1):15ā25.10.1016/0166-4328(85)90014-2
53
DalleyJWCardinalRNRobbinsTW. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev (2004) 28(7):771ā84.10.1016/j.neubiorev.2004.09.006
54
RunyanJDDashPK. Distinct prefrontal molecular mechanisms for information storage lasting seconds versus minutes. Learn Mem (2005) 12(3):232ā8.10.1101/lm.92405
55
RoozendaalBMcReynoldsJRMcGaughJL. The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment. J Neurosci (2004) 24(6):1385ā92.10.1523/JNEUROSCI.4664-03.2004
56
BuhlerMMannK. Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res (2011) 35(10):1771ā93.10.1111/j.1530-0277.2011.01540.x
57
NoelXSferrazzaRVan Der LindenMPaternotJVerhasMHanakCet alContribution of frontal cerebral blood flow measured by (99m)Tc-Bicisate spect and executive function deficits to predicting treatment outcome in alcohol-dependent patients. Alcohol Alcohol (2002) 37(4):347ā54.10.1093/alcalc/37.4.347
58
ButtsKAWeinbergJYoungAHPhillipsAG. Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function. Proc Natl Acad Sci U S A (2011) 108(45):18459ā64.10.1073/pnas.1111746108
59
LonzeBEGintyDD. Function and regulation of CREB family transcription factors in the nervous system. Neuron (2002) 35(4):605ā23.10.1016/S0896-6273(02)00828-0
60
PandeySCRoyAZhangHXuT. Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors. J Neurosci (2004) 24(21):5022ā30.10.1523/JNEUROSCI.5557-03.2004
61
MoonatSSakharkarAJZhangHTangLPandeySC. Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol Psychiatry (2013) 73(8):763ā73.10.1016/j.biopsych.2013.01.012
62
PandeySC. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci (2003) 24(9):456ā60.10.1016/S0165-6147(03)00226-8
63
ValdezGRKoobGF. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav (2004) 79(4):671ā89.10.1016/j.pbb.2004.09.020
64
JanakPHWolfFWHeberleinUPandeySCLogripMLRonD. BIG news in alcohol addiction: new findings on growth factor pathways BDNF, insulin, and GDNF. Alcohol Clin Exp Res (2006) 30(2):214ā21.10.1111/j.1530-0277.2006.00026.x
65
MoonatSStarkmanBGSakharkarAPandeySC. Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci (2010) 67(1):73ā88.10.1007/s00018-009-0135-y
66
MoonatSSakharkarAJZhangHPandeySC. The role of amygdaloid brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein and dendritic spines in anxiety and alcoholism. Addict Biol (2011) 16(2):238ā50.10.1111/j.1369-1600.2010.00275.x
67
CrewsFTNixonK. Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol (2009) 44(2):115ā27.10.1093/alcalc/agn079
68
PandeySCChartoffEHCarlezonWAJrZouJZhangHKreibichASet alCREB gene transcription factors: role in molecular mechanisms of alcohol and drug addiction. Alcohol Clin Exp Res (2005) 29(2):176ā84.10.1097/01.ALC.0000153550.31168.1D
69
HoffmanPLTabakoffB. Ethanol and guanine nucleotide binding proteins: a selective interaction. FASEB J (1990) 4(9):2612ā22.
70
WandGSLevineMA. Hormonal tolerance to ethanol is associated with decreased expression of the GTP-binding protein, Gs alpha, and adenylyl cyclase activity in ethanol-treated LS mice. Alcohol Clin Exp Res (1991) 15(4):705ā10.10.1111/j.1530-0277.1991.tb00583.x
71
CoeIRDohrmanDPConstantinescuADiamondIGordonAS. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. J Pharmacol Exp Ther (1996) 276(2):365ā9.
72
DohrmanDPChenHMGordonASDiamondI. Ethanol-induced translocation of protein kinase A occurs in two phases: control by different molecular mechanisms. Alcohol Clin Exp Res (2002) 26(3):407ā15.10.1111/j.1530-0277.2002.tb02553.x
73
ConstantinescuADiamondIGordonAS. Ethanol-induced translocation of cAMP-dependent protein kinase to the nucleus. Mechanism and functional consequences. J Biol Chem (1999) 274(38):26985ā91.10.1074/jbc.274.38.26985
74
AsherOCunninghamTDYaoLGordonASDiamondI. Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. J Pharmacol Exp Ther (2002) 301(1):66ā70.10.1124/jpet.301.1.66
75
NagyLEDeSilvaSE. Ethanol increases receptor-dependent cyclic AMP production in cultured hepatocytes by decreasing G(i)-mediated inhibition. Biochem J (1992) 286(Pt 3):681ā6.10.1042/bj2860681
76
SaitoTLuthinGRLeeJMHoffmanPLTabakoffB. Differential effects of ethanol on the striatal and cortical adenylate cyclase system. Jpn J Pharmacol (1987) 43(2):133ā41.10.1254/jjp.43.133
77
SaitoTLeeJMHoffmanPLTabakoffB. Effects of chronic ethanol treatment on the beta-adrenergic receptor-coupled adenylate cyclase system of mouse cerebral cortex. J Neurochem (1987) 48(6):1817ā22.10.1111/j.1471-4159.1987.tb05741.x
78
ValveriusPHoffmanPLTabakoffB. Hippocampal and cerebellar beta-adrenergic receptors and adenylate cyclase are differentially altered by chronic ethanol ingestion. J Neurochem (1989) 52(2):492ā7.10.1111/j.1471-4159.1989.tb09147.x
79
RodanARKigerJAJrHeberleinU. Functional dissection of neuroanatomical loci regulating ethanol sensitivity in Drosophila. J Neurosci (2002) 22(21):9490ā501.
80
ThieleTEWillisBStadlerJReynoldsJGBernsteinILMcKnightGS. High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. J Neurosci (2000) 20(10):RC75.
81
WandGLevineMZweifelLSchwindingerWAbelT. The cAMP-protein kinase A signal transduction pathway modulates ethanol consumption and sedative effects of ethanol. J Neurosci (2001) 21(14):5297ā303.
82
PandeySCRoyAMittalN. Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the creb gene transcription factor in rat cortex. J Pharmacol Exp Ther (2001) 296(3):857ā68.
83
Repunte-CanonigoVLutjensRvan der StapLDSannaPP. Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure. Brain Res (2007) 1138:48ā56.10.1016/j.brainres.2006.09.115
84
PandeySCZhangHRoyAXuT. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest (2005) 115(10):2762ā73.10.1172/JCI24381
85
WandG. The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism. J Clin Invest (2005) 115(10):2697ā9.10.1172/JCI26436
86
ZhangHPandeySC. Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal. Peptides (2003) 24(9):1397ā402.10.1016/j.peptides.2003.08.008
87
Badia-ElderNEStewartRBPowrozekTARoyKFMurphyJMLiTK. Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats. Alcohol Clin Exp Res (2001) 25(3):386ā90.10.1111/j.1530-0277.2001.tb02225.x
88
PrimeauxSDWilsonSPBrayGAYorkDAWilsonMA. Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self-administration in āanxiousā rats. Alcohol Clin Exp Res (2006) 30(5):791ā801.10.1111/j.1530-0277.2006.00092.x
89
ArnstenAF. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci (2009) 10(6):410ā22.10.1038/nrn2648
90
ShanskyRMLippsJ. Stress-induced cognitive dysfunction: hormone-neurotransmitter interactions in the prefrontal cortex. Front Hum Neurosci (2013) 7:123.10.3389/fnhum.2013.00123
91
GamoNJLurGHigleyMJWangMPaspalasCDVijayraghavanSet alStress impairs prefrontal cortical function via D1 dopamine receptor interactions with hyperpolarization-activated cyclic nucleotide-gated channels. Biol Psychiatry (2015) 78(12):860ā70.10.1016/j.biopsych.2015.01.009
92
BarsegyanAMackenzieSMKuroseBDMcGaughJLRoozendaalB. Glucocorticoids in the prefrontal cortex enhance memory consolidation and impair working memory by a common neural mechanism. Proc Natl Acad Sci U S A (2010) 107(38):16655ā60.10.1073/pnas.1011975107
93
LogripML. Phosphodiesterase regulation of alcohol drinking in rodents. Alcohol (2015) 49(8):795ā802.10.1016/j.alcohol.2015.03.007
94
HuWLuTChenAHuangYHansenRChandlerLJet alInhibition of phosphodiesterase-4 decreases ethanol intake in mice. Psychopharmacology (Berl) (2011) 218(2):331ā9.10.1007/s00213-011-2290-8
95
WenRTZhangMQinWJLiuQWangWPLawrenceAJet alThe phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. Alcohol Clin Exp Res (2012) 36(12):2157ā67.10.1111/j.1530-0277.2012.01845.x
96
FranklinKMHauserSRLasekAWMcClintickJDingZMMcBrideWJet alReduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). Psychopharmacology (Berl) (2015) 232(13):2251ā62.10.1007/s00213-014-3852-3
97
LogripMLZorrillaEP. Differential changes in amygdala and frontal cortex Pde10a expression during acute and protracted withdrawal. Front Integr Neurosci (2014) 8:30.10.3389/fnint.2014.00030
98
BaudonnatMGuillouJLHussonMVandesquilleMCorioMDecorteLet alDisrupting effect of drug-induced reward on spatial but not cue-guided learning: implication of the striatal protein kinase A/cAMP response element-binding protein pathway. J Neurosci (2011) 31(46):16517ā28.10.1523/JNEUROSCI.1787-11.2011
99
KoobGFLe MoalM. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology (2001) 24(2):97ā129.10.1016/S0893-133X(00)00195-0
100
VolkowNDFowlerJSWangGJGoldsteinRZ. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem (2002) 78(3):610ā24.10.1006/nlme.2002.4099
101
AhmedSHKoobGF. Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 282(5387):298ā300.10.1126/science.282.5387.298
102
MartinottiGNicolaMDReinaDAndreoliSFocaFCunniffAet alAlcohol protracted withdrawal syndrome: the role of anhedonia. Subst Use Misuse (2008) 43(3ā4):271ā84.10.1080/10826080701202429
103
JaniriLMartinottiGDarioTReinaDPaparelloFPozziGet alAnhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology (2005) 52(1):37ā44.10.1159/000086176
104
StevensonJRSchroederJPNixonKBesheerJCrewsFTHodgeCW. Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology (2009) 34(5):1209ā22.10.1038/npp.2008.90
105
PangTYRenoirTDuXLawrenceAJHannanAJ. Depression-related behaviours displayed by female C57BL/6J mice during abstinence from chronic ethanol consumption are rescued by wheel-running. Eur J Neurosci (2013) 37(11):1803ā10.10.1111/ejn.12195
106
LeeKMCoehloMMcGregorHAWaltermireRSSzumlinskiKK. Binge alcohol drinking elicits persistent negative affect in mice. Behav Brain Res (2015) 291:385ā98.10.1016/j.bbr.2015.05.055
107
BrionesTLRogozinskaMWoodsJ. Environmental experience modulates ischemia-induced amyloidogenesis and enhances functional recovery. J Neurotrauma (2009) 26(4):613ā25.10.1089/neu.2008.0707
108
YanTXuMWanSWangMWuBXiaoFet alSchisandra chinensis produces the antidepressant-like effects in repeated corticosterone-induced mice via the BDNF/TrkB/CREB signaling pathway. Psychiatry Res (2016) 243:135ā42.10.1016/j.psychres.2016.06.037
109
KouzaridesT. Chromatin modifications and their function. Cell (2007) 128(4):693ā705.10.1016/j.cell.2007.02.005
110
LathamJADentSY. Cross-regulation of histone modifications. Nat Struct Mol Biol (2007) 14(11):1017ā24.10.1038/nsmb1307
111
JaromeTJThomasJSLubinFD. The epigenetic basis of memory formation and storage. Prog Mol Biol Transl Sci (2014) 128:1ā27.10.1016/B978-0-12-800977-2.00001-2
112
GraffJMansuyIM. Epigenetic codes in cognition and behaviour. Behav Brain Res (2008) 192(1):70ā87.10.1016/j.bbr.2008.01.021
113
GraffJTsaiLH. Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci (2013) 14(2):97ā111.10.1038/nrn3427
114
DayJJSweattJD. Epigenetic mechanisms in cognition. Neuron (2011) 70(5):813ā29.10.1016/j.neuron.2011.05.019
115
ZovkicIBGuzman-KarlssonMCSweattJD. Epigenetic regulation of memory formation and maintenance. Learn Mem (2013) 20(2):61ā74.10.1101/lm.026575.112
116
DagnasMGuillouJLPrevotTMonsN. HDAC inhibition facilitates the switch between memory systems in young but not aged mice. J Neurosci (2013) 33(5):1954ā63.10.1523/JNEUROSCI.3453-12.2013
117
DagnasMMicheauJDecorteLBeracocheaDMonsN. Post-training, intrahippocampal HDAC inhibition differentially impacts neural circuits underlying spatial memory in adult and aged mice. Hippocampus (2015) 25(7):827ā37.10.1002/hipo.22406
118
GraffJTsaiLH. Cognitive enhancement: a molecular memory booster. Nature (2011) 469(7331):474ā5.10.1038/469474a
119
GraffJTsaiLH. The potential of HDAC inhibitors as cognitive enhancers. Annu Rev Pharmacol Toxicol (2013) 53:311ā30.10.1146/annurev-pharmtox-011112-140216
120
HaggartySJTsaiLH. Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity. Neurobiol Learn Mem (2011) 96(1):41ā52.10.1016/j.nlm.2011.04.009
121
SchneiderAChatterjeeSBousigesOSelviBRSwaminathanACasselRet alAcetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics (2013) 10(4):568ā88.10.1007/s13311-013-0204-7
122
VecseyCGHawkJDLattalKMSteinJMFabianSAAttnerMAet alHistone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci (2007) 27(23):6128ā40.10.1523/JNEUROSCI.0296-07.2007
123
StaffordJMRaybuckJDRyabininAELattalKM. Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction. Biol Psychiatry (2012) 72(1):25ā33.10.1016/j.biopsych.2011.12.012
124
KyzarEJPandeySC. Molecular mechanisms of synaptic remodeling in alcoholism. Neurosci Lett (2015) 601:11ā9.10.1016/j.neulet.2015.01.051
125
PandeySCUgaleRZhangHTangLPrakashA. Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci (2008) 28(14):3729ā37.10.1523/JNEUROSCI.5731-07.2008
126
PonomarevI. Epigenetic control of gene expression in the alcoholic brain. Alcohol Res (2013) 35(1):69ā76.
127
SakharkarAJZhangHTangLBaxstromKShiGMoonatSet alEffects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol (2014) 17(8):1207ā20.10.1017/S1461145714000054
128
SakharkarAJZhangHTangLShiGPandeySC. Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res (2012) 36(1):61ā71.10.1111/j.1530-0277.2011.01581.x
129
PandeySCZhangHUgaleRPrakashAXuTMisraK. Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism. J Neurosci (2008) 28(10):2589ā600.10.1523/JNEUROSCI.4752-07.2008
130
YouCZhangHSakharkarAJTeppenTPandeySC. Reversal of deficits in dendritic spines, BDNF and Arc expression in the amygdala during alcohol dependence by HDAC inhibitor treatment. Int J Neuropsychopharmacol (2014) 17(2):313ā22.10.1017/S1461145713001144
131
PrakashAZhangHPandeySC. Innate differences in the expression of brain-derived neurotrophic factor in the regions within the extended amygdala between alcohol preferring and nonpreferring rats. Alcohol Clin Exp Res (2008) 32(6):909ā20.10.1111/j.1530-0277.2008.00650.x
132
AgudeloMGandhiNSaiyedZPichiliVThangavelSKhatavkarPet alEffects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). Alcohol Clin Exp Res (2011) 35(8):1550ā6.10.1111/j.1530-0277.2011.01492.x
133
Simon-OāBrienEAlaux-CantinSWarnaultVButtoloRNaassilaMVilpouxC. The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals. Addict Biol (2015) 20(4):676ā89.10.1111/adb.12161
134
SmithMLLopezMFArcherKJWolenARBeckerHCMilesMF. Time-course analysis of brain regional expression network responses to chronic intermittent ethanol and withdrawal: implications for mechanisms underlying excessive ethanol consumption. PLoS One (2016) 11(1):e0146257.10.1371/journal.pone.0146257
135
PascualMBalinoPAlfonso-LoechesSAragonCMGuerriC. Impact of TLR4 on behavioral and cognitive dysfunctions associated with alcohol-induced neuroinflammatory damage. Brain Behav Immun (2011) 25(Suppl 1):S80ā91.10.1016/j.bbi.2011.02.012
136
Paula-BarbosaMMPereiraPACadete-LeiteADulce MadeiraM. NGF and NT-3 exert differential effects on the expression of neuropeptides in the suprachiasmatic nucleus of rats withdrawn from ethanol treatment. Brain Res (2003) 983(1ā2):64ā73.10.1016/S0006-8993(03)03030-0
137
PhillipsSCCraggBG. Blood-brain barrier dysfunction in thiamine-deficient, alcohol-treated rats. Acta Neuropathol (1984) 62(3):235ā41.10.1007/BF00691858
138
FarrSAScherrerJFBanksWAFloodJFMorleyJE. Chronic ethanol consumption impairs learning and memory after cessation of ethanol. Alcohol Clin Exp Res (2005) 29(6):971ā82.10.1097/01.ALC.0000171038.03371.56
139
LukoyanovNVPereiraPAPaula-BarbosaMMCadete-LeiteA. Nerve growth factor improves spatial learning and restores hippocampal cholinergic fibers in rats withdrawn from chronic treatment with ethanol. Exp Brain Res (2003) 148(1):88ā94.10.1007/s00221-002-1290-7
140
LukoyanovNVMadeiraMDPaula-BarbosaMM. Behavioral and neuroanatomical consequences of chronic ethanol intake and withdrawal. Physiol Behav (1999) 66(2):337ā46.10.1016/S0031-9384(98)00301-1
141
CollinsAHillLEChandramohanYWhitcombDDrosteSKReulJM. Exercise improves cognitive responses to psychological stress through enhancement of epigenetic mechanisms and gene expression in the dentate gyrus. PLoS One (2009) 4(1):e4330.10.1371/journal.pone.0004330
142
Bilang-BleuelAUlbrichtSChandramohanYDe CarliSDrosteSKReulJM. Psychological stress increases histone H3 phosphorylation in adult dentate gyrus granule neurons: involvement in a glucocorticoid receptor-dependent behavioural response. Eur J Neurosci (2005) 22(7):1691ā700.10.1111/j.1460-9568.2005.04358.x
143
ChandramohanYDrosteSKArthurJSReulJM. The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-d-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway. Eur J Neurosci (2008) 27(10):2701ā13.10.1111/j.1460-9568.2008.06230.x
144
ReulJMHeskethSACollinsAMecinasMG. Epigenetic mechanisms in the dentate gyrus act as a molecular switch in hippocampus-associated memory formation. Epigenetics (2009) 4(7):434ā9.10.4161/epi.4.7.9806
145
Gutierrez-MecinasMTrollopeAFCollinsAMorfettHHeskethSAKersanteFet alLong-lasting behavioral responses to stress involve a direct interaction of glucocorticoid receptors with ERK1/2-MSK1-Elk-1 signaling. Proc Natl Acad Sci U S A (2011) 108(33):13806ā11.10.1073/pnas.1104383108
146
McClainJANixonK. Alcohol induces parallel changes in hippocampal histone H3 phosphorylation and c-fos protein expression in male rats. Alcohol Clin Exp Res (2016) 40(1):102ā12.10.1111/acer.12933
147
ChwangWBOāRiordanKJLevensonJMSweattJD. ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem (2006) 13(3):322ā8.10.1101/lm.152906
148
ChwangWBArthurJSSchumacherASweattJD. The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation. J Neurosci (2007) 27(46):12732ā42.10.1523/JNEUROSCI.2522-07.2007
149
GenouxDHaditschUKnoblochMMichalonAStormDMansuyIM. Protein phosphatase 1 is a molecular constraint on learning and memory. Nature (2002) 418(6901):970ā5.10.1038/nature00928
150
KoshibuKGraffJMansuyIM. Nuclear protein phosphatase-1: an epigenetic regulator of fear memory and amygdala long-term potentiation. Neuroscience (2011) 173:30ā6.10.1016/j.neuroscience.2010.11.023
151
KoshibuKGraffJBeullensMHeitzFDBerchtoldDRussigHet alProtein phosphatase 1 regulates the histone code for long-term memory. J Neurosci (2009) 29(41):13079ā89.10.1523/JNEUROSCI.3610-09.2009
152
GraffJKimDDobbinMMTsaiLH. Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol Rev (2011) 91(2):603ā49.10.1152/physrev.00012.2010
153
ZhouZYuanQMashDCGoldmanD. Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol. Proc Natl Acad Sci U S A (2011) 108(16):6626ā31.10.1073/pnas.1018514108
154
StragierEMassartRSaleryMHamonMGenyDMartinVet alEthanol-induced epigenetic regulations at the Bdnf gene in C57BL/6J mice. Mol Psychiatry (2015) 20(3):405ā12.10.1038/mp.2014.38
155
QiangMDennyALieuMCarreonSLiJ. Histone H3K9 modifications are a local chromatin event involved in ethanol-induced neuroadaptation of the NR2B gene. Epigenetics (2011) 6(9):1095ā104.10.4161/epi.6.9.16924
156
QiangMDennyAChenJTickuMKYanBHendersonG. The site specific demethylation in the 5ā-regulatory area of NMDA receptor 2B subunit gene associated with CIE-induced up-regulation of transcription. PLoS One (2010) 5(1):e8798.10.1371/journal.pone.0008798
157
QiangMLiJGDennyADYaoJMLieuMZhangKet alEpigenetic mechanisms are involved in the regulation of ethanol consumption in mice. Int J Neuropsychopharmacol (2015) 18(2):1ā11.10.1093/ijnp/pyu072
Summary
Keywords
alcoholism, epigenetic, learning and memory, glucocorticoid, anxiety, signaling, CREB, brain
Citation
Mons N and Beracochea D (2016) Behavioral Neuroadaptation to Alcohol: From Glucocorticoids to Histone Acetylation. Front. Psychiatry 7:165. doi: 10.3389/fpsyt.2016.00165
Received
30 May 2016
Accepted
21 September 2016
Published
06 October 2016
Volume
7 - 2016
Edited by
Stefan Borgwardt, University of Basel, Switzerland
Reviewed by
Giovanni Martinotti, UniversitĆ degli Studi āG. dāAnnunzioā Chieti ā Pescara, Italy; Diana Martinez, Columbia University, USA
Updates
Copyright
Ā© 2016 Mons and Beracochea.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nicole Mons, nicole.mons@u-bordeaux.fr
Specialty section: This article was submitted to Addictive Disorders, a section of the journal Frontiers in Psychiatry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.